Sponsored Content|Webinar|Treatment Planning| May 15, 2017

WEBINAR: Advances in CT to Enhance Radiation Therapy Planning

This webinar is sponsored by Philips Healthcare

Philips_SmartArc

The webinar "Advances in Computed Tomography (CT) to Enhance Radiation Therapy Planning," will offer an overview of the use of CT simulation in radiation therapy and the technologies available to reduce image artifacts that may impact the quality of care.

The webinar took place June 7, 2017, and the archive version is available immediately when you register.

Register for this webinar

本次网络研讨会由飞利浦医疗集团赞助。

Statement of Purpose
CT simulation is the current standard of care for radiation therapy treatment planning due to its excellent geometric fidelity and relationship to material density required for dose calculation. However, image artifacts may be detrimental to treatment planning accuracy. This talk will describe the state of the art of CT artifact reduction, particularly for metal artifacts and potential impacts on radiation therapy planning. Furthermore, as we image more frequently for adaptive planning purposes and adhere to as low as reasonably achievable (ALARA) principles, dose reduction and image optimization without information loss is essential. Concepts such as incorporating advanced CT reconstruction algorithms such as iterative and model-based reconstruction will be discussed. The impact of using these algorithms in the context of radiation therapy will be described. Finally, consideration will be given to emerging CT applications on the horizon.

Learning Objectives
Upon completion of this activity, participants will be able to:

• Review causes of CT image artifacts and potential impacts on treatment planning.
• Explain the state of the art for metal artifact reduction technologies in CT and their potential impact on clinical treatment planning.
• Define typical CT doses in the context of radiation therapy.
• Discuss existing CT technologies to lower dose in image acquisition and examine the potential clinical impact in radiation oncology.
描述正在开发和使用的新兴CT在放射肿瘤学中的应用。

Intended Audience:
This activity is intended for radiation oncologists, medical physicists, dosimetrists, and all staff involved in imaging used for oncology treatment planning and simulation.

Speaker:

Carri K. Glide-Hurst, Ph.D., DABRCarri K. Glide-Hurst, Ph.D., DABR
Director of Translational Research
Henry Ford Health System

Glide-Hurst于2007年获得韦恩州立大学医学物理学博士学位,专注于乳腺超声断层扫描和利用声学参数进行乳腺密度评估。随后,她在威廉博蒙特医院的放射肿瘤科进行了两年的博士后培训,重点是肺癌的运动管理技术。此后,她一直在底特律的Henry Ford Health Systems工作,目前担任转化研究主任。她的主要临床和研究重点包括将CT和MR模拟(MR- sim)应用于放射肿瘤学和治疗规划。glid - hurst是AAPM 284任务组的联合主席-磁共振成像-放疗模拟:临床实施、优化和质量保证的考虑。格莱德-赫斯特获得了美国国立卫生研究院R01拨款,用于发展解剖病人模型,以促进仅mr治疗计划。她发表了超过35篇同行评议的出版物和大约100篇与放射治疗成像相关的摘要。

Register for this webinar

Related Content

News|Radiology Imaging

August 11, 2022 — Bracco Imaging S.p.A. has announced the renewal of the “Bracco Fellowships” initiative, in partnership ...

TimeAugust 11, 2022
arrow
Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

2022年8月10日—西奈山大学领导的一个肺癌研究团队获得了一项为期三年、价值50万美元的奖金……

TimeAugust 10, 2022
arrow
Feature|Magnetic Resonance Imaging (MRI)| Christine Book

August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...

TimeAugust 10, 2022
arrow
Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

2022年8月8日-美国食品和药物管理局批准了Enhertu (fam-曲妥珠单抗-德鲁克特康-nxki),一种IV…

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

2022年8月5日消息——IBA (Ion Beam Applications s.a., EURONEXT)是全球领先的粒子加速器技术公司,Fred…

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON — a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system.
News|Computed Tomography (CT)

August 4, 2022 — Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON — a truly mobile ...

TimeAugust 04, 2022
arrow
Subscribe Now